Figure 2From: Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib Follow-up after complete remission achieved, there is no recurrence of tumor. (a) Week 23 of targeted therapy, the tumor has completely disappeared; (b) year 2 of targeted therapy, the tumor has completely disappeared; (c) year 3 of targeted therapy, the tumor has completely disappeared.Back to article page